| Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer (NCT03759587) | Takeda | 2018-12-28 |
| A Phosphate Binder Switch Study of KHK7791 in Hyperphosphatemia Patients on HD (NCT03831607) | Kyowa Kirin Co., Ltd. | 2018-12-27 |
| A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (NCT03706040) | AbbVie | 2018-12-27 |
| Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With Schizophrenia (NCT03793712) | H. Lundbeck A/S | 2018-12-27 |
| Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) (NCT03420014) | Philogen S.p.A. | 2018-12-27 |
| FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer (NCT03944434) | Fondazione Sandro Pitigliani | 2018-12-27 |
| Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS (NCT03699475) | Bellicum Pharmaceuticals | 2018-12-27 |
| A Maximal Use Trial Evaluating the Pharmacokinetic Profile of MC2-01 Cream in Adolescent Subjects (NCT03819218) | MC2 Therapeutics | 2018-12-27 |
| Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung Cancer (NCT03647488) | Novartis Pharmaceuticals | 2018-12-26 |
| Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (NCT03458260) | The Lymphoma Academic Research Organisation | 2018-12-26 |
| PSD502 in Subjects With Premature Ejaculation (NCT03578783) | Plethora Solutions Ltd | 2018-12-26 |
| Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian Cancer (NCT03759600) | Takeda | 2018-12-26 |
| Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children (NCT04513171) | Xiamen Amoytop Biotech Co., Ltd. | 2018-12-26 |
| Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain (NCT03692403) | Ferring Pharmaceuticals | 2018-12-26 |
| Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA) (NCT03912402) | Biocad | 2018-12-25 |
| TNT to Increase the Clinical Complete Response Rate for Distal LARC (NCT03840239) | Sun Yat-sen University | 2018-12-25 |
| Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy (NCT03712397) | National Health Research Institutes, Taiwan | 2018-12-24 |
| Use of Bone Marrow Derived Stem Cell and G-CSF With Circulatory Assistance in the Treatment of DCM (NCT03572660) | Barts & The London NHS Trust | 2018-12-24 |
| Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer (NCT03559049) | University of Michigan Rogel Cancer Center | 2018-12-24 |
| Efficacy and Safety of SYN-010 in IBS-C (NCT03763175) | Cedars-Sinai Medical Center | 2018-12-24 |
| RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer (NCT03675893) | Dana-Farber Cancer Institute | 2018-12-24 |
| Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma (NCT03523975) | City of Hope Medical Center | 2018-12-24 |
| Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6 (NCT03618758) | Seoul National University Bundang Hospital | 2018-12-24 |
| Ixazomib Maintenance in Patients With Newly Diagnosed Mantle Cell Lymphoma(MCL) (NCT03616782) | Ho Sup Lee | 2018-12-24 |
| A Study of Pyrotinib Plus Vinorelbine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer (NCT03933982) | Chinese Academy of Medical Sciences | 2018-12-22 |
| Immunogenicity and Safety Study of NBP615 in Healthy Female (NCT04453241) | SK Bioscience Co., Ltd. | 2018-12-22 |
| Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION) (NCT03775486) | AstraZeneca | 2018-12-21 |
| Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) (NCT03852472) | Amgen | 2018-12-21 |
| Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis (NCT03778008) | Second Affiliated Hospital of Nanchang University | 2018-12-21 |
| A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma. (NCT03815058) | Genentech, Inc. | 2018-12-21 |
| Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months (NCT05229536) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2018-12-21 |
| Anlotinib Combined With Docetaxel Versus Docetaxel for Previous Treated Advanced NSCLC (NCT03726736) | Yong Fang | 2018-12-21 |
| A Safety Study of BBI-4000 Gel in Pediatric Patients With Axillary Hyperhidrosis (NCT03785587) | Botanix Pharmaceuticals | 2018-12-21 |
| Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus (NCT03742037) | Viatris Innovation GmbH | 2018-12-21 |
| A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer (NCT03742102) | AstraZeneca | 2018-12-21 |
| Short-term Testosterone Replacement in Testicular Cancer Survivors (NCT03339635) | University Medical Center Groningen | 2018-12-21 |
| Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas (NCT03038672) | National Cancer Institute (NCI) | 2018-12-21 |
| Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian Cancer (NCT03602586) | National Cancer Institute (NCI) | 2018-12-21 |
| Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors (NCT03836352) | ImmunoVaccine Technologies, Inc. (IMV Inc.) | 2018-12-21 |
| Evaluate the Safety and Tolerability, as Well as the Pharmacokinetic and Pharmacodynamic Profiles of Single and Multiple Doses of Eplontersen Administered Subcutaneously to Healthy Volunteers and Patients With Hereditary Transthyretin-Mediated Amyloidosis (hATTR ). (NCT03728634) | Ionis Pharmaceuticals, Inc. | 2018-12-21 |
| Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients (NCT03866577) | Momenta Pharmaceuticals, Inc. | 2018-12-21 |
| A Study to Assess Dystrophin Levels in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) (NCT03648827) | PTC Therapeutics | 2018-12-21 |
| A Study of Oraxol in Subjects With Cutaneous Angiosarcoma (NCT03544567) | Athenex, Inc. | 2018-12-21 |
| Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes (NCT03824080) | GWT-TUD GmbH | 2018-12-20 |
| A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities (NCT03639987) | Biogen | 2018-12-20 |
| The Effect of Chinese Herbal Medicine for Reducing the Application of Antibiotics in the Treatment of Acute Mastitis (NCT03756324) | Beijing University of Chinese Medicine | 2018-12-20 |
| Tocilizumab in Cardiac Transplantation (NCT03644667) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-12-20 |
| Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer (NCT03724851) | MedPacto, Inc. | 2018-12-20 |
| A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients (NCT03780543) | Assembly Biosciences | 2018-12-20 |
| Study of TVEC in Patients With Cutaneous Squamous Cell Cancer (NCT03714828) | University of Arizona | 2018-12-20 |
| A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (NCT03760666) | Clear Creek Bio, Inc. | 2018-12-20 |
| Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness (NCT03772340) | Vanda Pharmaceuticals | 2018-12-20 |
| TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (NCT03686488) | H. Lee Moffitt Cancer Center and Research Institute | 2018-12-20 |
| A Study Comparing Immunotherapy With Chemotherapy in the Treatment of Elderly Patients With Advanced NSCLC (MILES-5) (NCT03975114) | National Cancer Institute, Naples | 2018-12-20 |
| Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC (NCT05498896) | Queen Mary University of London | 2018-12-19 |
| A Study in Patients With Trichotillomania (NCT03797521) | Promentis Pharmaceuticals, Inc. | 2018-12-19 |
| M7824 in People With Recurrent Respiratory Papillomatosis (NCT03707587) | National Cancer Institute (NCI) | 2018-12-19 |
| Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia (NCT03802201) | Protagonist Therapeutics, Inc. | 2018-12-19 |
| Evaluation of the Safety and Efficacy of the Association of Ibrutinib and Daratumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia With p53 Dysfunction (NCT03734198) | French Innovative Leukemia Organisation | 2018-12-19 |
| A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis (NCT03759041) | Seres Therapeutics, Inc. | 2018-12-19 |
| Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma (NCT03737123) | Nabil Adra | 2018-12-19 |
| A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer (NCT03674112) | Hoffmann-La Roche | 2018-12-19 |
| Multiorgan Metabolic Imaging Response Assessment of Abemaciclib (NCT03339843) | Jules Bordet Institute | 2018-12-19 |
| Clinical Study of ICP-192 in Solid Tumors Patients (NCT03758664) | Beijing InnoCare Pharma Tech Co., Ltd. | 2018-12-19 |
| An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051 (Vesleteplirsen) (NCT03675126) | Sarepta Therapeutics, Inc. | 2018-12-19 |
| Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients (NCT03656562) | Novartis Pharmaceuticals | 2018-12-19 |
| Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC (NCT03822351) | MedImmune LLC | 2018-12-19 |
| Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT) (NCT03594045) | Massachusetts General Hospital | 2018-12-18 |
| MT2017-45: CAR-T Cell Therapy for Heme Malignancies (NCT03642626) | Masonic Cancer Center, University of Minnesota | 2018-12-18 |
| 2017 A/H7N9 IIV Revaccination (NCT03738241) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-12-18 |
| T-DM1 and Osimertinib Combination Treatment to Target HER2 Bypass Track Resistance in EGFR Mutation Positive NSCLC (NCT03784599) | The Netherlands Cancer Institute | 2018-12-18 |
| Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis (NCT03764475) | Arcutis Biotherapeutics, Inc. | 2018-12-18 |
| ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors (NCT03802123) | ImaginAb, Inc. | 2018-12-18 |
| Steroids and Pain Control After Tonsillectomy (NCT03995628) | Medical University of South Carolina | 2018-12-18 |
| Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" Study (NCT03840005) | Sheffield Teaching Hospitals NHS Foundation Trust | 2018-12-18 |
| Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting (NCT03776721) | Odense University Hospital | 2018-12-18 |
| Compare Apatinib Plus Capecitabine Versus Capecitabine in Maintenance Therapy for Patients With Advanced Triple-negative Breast Cancer (NCT03775928) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2018-12-18 |
| Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects (NCT03719664) | Frontier Biotechnologies Inc. | 2018-12-17 |
| Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy (NCT03804879) | Novartis Pharmaceuticals | 2018-12-17 |
| Lenvatinib Plus PD-1 Antibody for Unresectable ICC (NCT03779100) | Shi Ming | 2018-12-17 |
| Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) (NCT03388749) | Moleculin Biotech, Inc. | 2018-12-17 |
| Study of AAVrh10-h.SGSH Gene Therapy in Patients With Mucopolysaccharidosis Type IIIA (MPS IIIA) (NCT03612869) | LYSOGENE | 2018-12-17 |
| Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation (NCT03807037) | Monash University Malaysia | 2018-12-17 |
| Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial Trunk (NCT03819985) | M.D. Anderson Cancer Center | 2018-12-17 |
| Immunogenicity and Safety Study of a Vaccine Against Lyme Borreliosis, in Healthy Adults Aged 18 to 65 Years. Randomized, Controlled, Observer-blind Phase 2 Study. (NCT03769194) | Pfizer | 2018-12-17 |
| Pharmacological Intervention for Symptomatic Snoring (NCT03720353) | Brigham and Women's Hospital | 2018-12-17 |
| FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD (NCT03846193) | Gyroscope Therapeutics Limited | 2018-12-17 |
| Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia (NCT03634228) | M.D. Anderson Cancer Center | 2018-12-17 |
| Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function (NCT03718533) | Novartis Pharmaceuticals | 2018-12-17 |
| Effect of the Administration of L-Carnitine on Body Weight in Women in Crossfit Training (NCT03436277) | University of Guadalajara | 2018-12-17 |
| A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer (NCT03796429) | Shanghai Zhongshan Hospital | 2018-12-17 |
| Norepinephrine Boluses in Liver Transplantation (NCT03773276) | Mansoura University | 2018-12-17 |
| Phase II of Lenvatinib Plus PD-1 Antibody for Advanced HCC (NCT03746249) | Sun Yat-sen University | 2018-12-17 |
| Usefulness of Non TNF Usage in RA Patients (NCT03784261) | Shinshu University | 2018-12-17 |
| Comparison Of The Effect Of Propolis And Gluma Desensitizer On The Management Of Dentin Hypersensitivity (NCT04819867) | Dow University of Health Sciences | 2018-12-16 |
| Adipose Stem/Stromal Cells in RSD, CRPS, Fibromyalgia (NCT02987855) | Healeon Medical Inc | 2018-12-15 |
| Does Induction Dosage in Latent Phase Affect Active Phase of Labor? (NCT03742531) | Zeynep Kamil Maternity and Pediatric Research and Training Hospital | 2018-12-15 |
| Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors (NCT03600233) | TaiRx, Inc. | 2018-12-15 |
| Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy (NCT03743155) | Institut de Terapia Regenerativa Tissular | 2018-12-15 |
| Adjuvant Therapy With Anlotinib for HCC (NCT04947371) | Shanghai Zhongshan Hospital | 2018-12-15 |